A compelling body of research indicates an immune-independent tumor cell proliferation and oncogenic signals triggered by intrinsic PD-L1 in melanoma, ovarian cancer, and head and neck cancer [25,26,27]. This evidence concerns the gene CD274 and ovarian carcinoma.